Long-term safety of targeted agents used to treat metastatic renal cell carcinoma: The issue is not the rate of adverse events over time, but the expertise needed to manage them

Camillo Porta, Silvia Chiellino

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)S613-S615
JournalTranslational Cancer Research
Volume5
DOIs
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

@article{2c9cf450d82545c085ea73bdf37ecc7e,
title = "Long-term safety of targeted agents used to treat metastatic renal cell carcinoma: The issue is not the rate of adverse events over time, but the expertise needed to manage them",
author = "Camillo Porta and Silvia Chiellino",
year = "2016",
doi = "10.21037/tcr.2016.09.41",
language = "English",
volume = "5",
pages = "S613--S615",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Long-term safety of targeted agents used to treat metastatic renal cell carcinoma

T2 - The issue is not the rate of adverse events over time, but the expertise needed to manage them

AU - Porta, Camillo

AU - Chiellino, Silvia

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84992111045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992111045&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.09.41

DO - 10.21037/tcr.2016.09.41

M3 - Letter

AN - SCOPUS:84992111045

VL - 5

SP - S613-S615

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -